國立虎尾科技大學 |

The Carbonic Anhydrases: Current and Emerging Therapeutic Targets

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	The Carbonic Anhydrases: Current and Emerging Therapeutic Targets/ edited by W. Richard Chegwidden, Nicholas D. Carter.
其他作者:	Carter, Nicholas D.
面頁冊數:	XII, 288 p. 38 illus., 22 illus. in color.online resource. :
Contained By:	Springer Nature eBook
標題:	Medical Biochemistry. -
電子資源:	https://doi.org/10.1007/978-3-030-79511-5
ISBN:	9783030795115

The Carbonic Anhydrases: Current and Emerging Therapeutic Targets
The Carbonic Anhydrases: Current and Emerging Therapeutic Targets[electronic resource] /edited by W. Richard Chegwidden, Nicholas D. Carter. - 1st ed. 2021. - XII, 288 p. 38 illus., 22 illus. in color.online resource. - Progress in Drug Research,752297-4555 ;. - Progress in Drug Research,70.

Dedication -- Preface.-The carbonic anhydrases in health and disease -- Carbonic anhydrase isozymes as diagnostic biomarkers and therapeutic targets -- Targeting carbonic anhydrases in vascular and pulmonary disease -- Carbonic anhydrase inhibitors in ophthalmology: glaucoma and macular oedema -- Targeting carbonic anhydrase isozymes in the treatment of neurological disorders -- Potential of carbonic anhydrase inhibitors in the treatment of oxidative stress and diabetes -- An overview of carbonic anhydrase-related neoplasms -- The carbonic anhydrase IX interactome and the regulation of cancer progression -- Carbonic anhydrase IX: current and emerging therapies -- Carbonic anhydrase inhibitors: designing isozyme-specific inhibitors as therapeutic agents -- Carbonic anhydrase inhibitors: identifying therapeutic cancer agents through virtual screening -- Targeting carbonic anhydrase IX in tumour imaging and theranostic cancer therapy.

This volume assembles and integrates the wealth of diverse information that is now accumulating in this burgeoning field. The existing and potential therapeutic applications of targeting CA cover a remarkably wide-range of diseases and disorders and have generated increasing and extensive interest in recent years. Its inter-disciplinary approach embraces both the most up-to-date therapeutic application of CA-targeting and the latest research data that will provide a platform for the development of novel applications. The interested audience comprises scientists and clinicians from many relevant disciplines within science and medicine.

ISBN: 9783030795115

Standard No.: 10.1007/978-3-030-79511-5doiSubjects--Topical Terms:

668897
Medical Biochemistry.

LC Class. No.: RM1-950

Dewey Class. No.: 615

The Carbonic Anhydrases: Current and Emerging Therapeutic Targets
LDR:03053nam a22004095i 4500 001 1056780
003 DE-He213
005 20211030111004.0
007 cr nn 008mamaa
008 220103s2021 sz | s |||| 0|eng d
020 $a 9783030795115 $9 978-3-030-79511-5
024 7 $a 10.1007/978-3-030-79511-5 $2 doi
035 $a 978-3-030-79511-5
050 4 $a RM1-950
072 7 $a MMG $2 bicssc
072 7 $a MED071000 $2 bisacsh
072 7 $a MKG $2 thema
082 0 4 $a 615 $2 23
245 1 4 $a The Carbonic Anhydrases: Current and Emerging Therapeutic Targets $h [electronic resource] / $c edited by W. Richard Chegwidden, Nicholas D. Carter.
250 $a 1st ed. 2021.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2021.
300 $a XII, 288 p. 38 illus., 22 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
490 1 $a Progress in Drug Research, $x 2297-4555 ; $v 75
505 0 $a Dedication -- Preface.-The carbonic anhydrases in health and disease -- Carbonic anhydrase isozymes as diagnostic biomarkers and therapeutic targets -- Targeting carbonic anhydrases in vascular and pulmonary disease -- Carbonic anhydrase inhibitors in ophthalmology: glaucoma and macular oedema -- Targeting carbonic anhydrase isozymes in the treatment of neurological disorders -- Potential of carbonic anhydrase inhibitors in the treatment of oxidative stress and diabetes -- An overview of carbonic anhydrase-related neoplasms -- The carbonic anhydrase IX interactome and the regulation of cancer progression -- Carbonic anhydrase IX: current and emerging therapies -- Carbonic anhydrase inhibitors: designing isozyme-specific inhibitors as therapeutic agents -- Carbonic anhydrase inhibitors: identifying therapeutic cancer agents through virtual screening -- Targeting carbonic anhydrase IX in tumour imaging and theranostic cancer therapy.
520 $a This volume assembles and integrates the wealth of diverse information that is now accumulating in this burgeoning field. The existing and potential therapeutic applications of targeting CA cover a remarkably wide-range of diseases and disorders and have generated increasing and extensive interest in recent years. Its inter-disciplinary approach embraces both the most up-to-date therapeutic application of CA-targeting and the latest research data that will provide a platform for the development of novel applications. The interested audience comprises scientists and clinicians from many relevant disciplines within science and medicine.
650 2 4 $a Medical Biochemistry. $3 668897
650 1 4 $a Pharmacology/Toxicology. $3 593882
650 0 $a Pharmacy. $3 582411
650 0 $a Medical biochemistry. $3 1254555
650 0 $a Pharmacology. $3 583819
700 1 $a Carter, Nicholas D. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1362139
700 1 $a Chegwidden, W. Richard. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1362138
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783030795108
776 0 8 $i Printed edition: $z 9783030795122
776 0 8 $i Printed edition: $z 9783030795139
830 0 $a Progress in Drug Research, $x 0071-786X ; $v 70 $3 1258680
856 4 0 $u https://doi.org/10.1007/978-3-030-79511-5
912 $a ZDB-2-SBL
912 $a ZDB-2-SXB
950 $a Biomedical and Life Sciences (SpringerNature-11642)
950 $a Biomedical and Life Sciences (R0) (SpringerNature-43708)